Inspire Medical Systems, Inc. (INSP) earnings

INSP earnings moved a median of +1.20% by the close. Quarterly and annual INSP reports and results, each read against the price at its own news timestamp. Back to the INSP overview →

28 measured INSP earnings events.

Where these INSP earnings landedvs 28 measured INSP earnings reactions
INSP earningsMiddle 50% · -0.86% to +6.33%Zero: 0.00%Median: +1.20%Median +1.20%-8.00%0+8.00%
Middle 50% of INSP earnings reactions-0.86% to +6.33%
Median reaction (to close)+1.20%
Measured reactions28
Point-in-time · zero look-ahead

Half of the 28 INSP earnings events with a measured close landed between -0.86% and +6.33%; 64% closed up.

DateHeadlineEvent5-minTo close
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026Press release+0.43%-4.25%
Form 10-Q Inspire Medical Systems, For: Jun 30SEC filing · Form 10-Q-2.55%+1.25%
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth PlanPress release-2.55%+1.25%
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026Press release+0.38%+4.21%
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026Press release+1.00%+6.41%
Form 10-Q Inspire Medical Systems, For: Mar 31SEC filing · Form 10-Q-4.04%+2.66%
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 GuidancePress release-4.04%+2.66%
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026Press release-0.23%-4.02%
Form 10-K Inspire Medical Systems, For: Dec 31SEC filing · Form 10-K+4.93%-0.36%
Form 10-Q Inspire Medical Systems, For: Sep 30SEC filing · Form 10-Q-0.66%+1.20%
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 OutlookPress release-0.66%+1.20%
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025Press release-0.95%-1.07%
Form 10-Q Inspire Medical Systems, For: Jun 30SEC filing · Form 10-Q-1.42%+6.33%
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 OutlookPress release-1.42%+6.33%
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025Press release-0.27%-0.66%
Form 10-Q Inspire Medical Systems, For: Mar 31SEC filing · Form 10-Q+0.86%+12.81%
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 OutlookPress release+0.86%+12.81%
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025Press release-0.24%-0.79%
Form 10-K Inspire Medical Systems, For: Dec 31SEC filing · Form 10-K+3.27%+7.92%
Form 10-Q Inspire Medical Systems, For: Sep 30SEC filing · Form 10-Q-3.68%+0.09%
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 OutlookPress release-3.68%+0.09%
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024Press release-0.96%-3.07%
Form 10-Q Inspire Medical Systems, For: Jun 30SEC filing · Form 10-Q-0.55%+10.81%
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 OutlookPress release-0.55%+10.81%
Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024Press release-0.98%-3.54%
Form 10-Q Inspire Medical Systems, For: Mar 31SEC filing · Form 10-Q-2.61%-9.22%
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 OutlookPress release-2.61%-9.22%
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024Press release+0.23%+0.01%
That’s how INSP usually reacts to earnings — get an email when it moves on news →
Keep exploring

More INSP: analyst actions → · SEC filings → · INSP overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Cytokinetics, Incorporated (CYTK)1,706+0.02%50%
MYLAN NV ORDINARY SHARES (MYL)1,701-0.13%44%
AstraZeneca PLC Ordinary Shares (AZN)1,632+0.03%54%
Alexion Pharmaceuticals, Inc (ALXN)1,615-0.04%49%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.